Fundraising FoxScene
Baltimore, US · 8 known investors
Find your way into Scene
Sign up to see every warm intro you have to Scene
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Scene team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Scene provides digital medication adherence programs combining video check-ins and human engagement by nurses and pharmacists to improve patient adherence and health outcomes across health systems and care organizations. The company evolved from emocha, a Johns Hopkins-originated technology that has expanded globally to address medication nonadherence in infectious disease treatment and other conditions.
Founders & leadership
Investors · 8
__Twitter.png)
How we know: Kapor Capital's portfolio page · funding news · Not right? Tell us
How we know: TCP Venture Capital's portfolio page · Not right? Tell us
How we know: funding news · Not right? Tell us
How we know: press coverage · Not right? Tell us
How we know: press coverage · Not right? Tell us
How we know: funding news · Not right? Tell us
How we know: press coverage · Not right? Tell us
Non-dilutive funding · 10 SBIR/STTR awards
Federal grants — no equity taken| Agency | Phase | Year | Amount |
|---|---|---|---|
| National Institutes of Health (NIH)National Institutes of Health | Phase II | 2023 | $838.6K |
| National Institutes of Health (NIH)National Institutes of Health | Phase II | 2023 | $654.5K |
| National Institutes of Health (NIH)National Institutes of Health | Phase II | 2023 | $642.8K |
| National Institutes of Health (NIH)National Institutes of Health | Phase II | 2020 | $1.5M |
| National Institutes of Health (NIH)National Institutes of Health | Phase ISTTR | 2020 | $224.9K |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2019 | $222K |
| National Institutes of Health (NIH)National Institutes of Health | Phase II | 2018 | $2.5M |
| National Institutes of Health (NIH)National Institutes of Health | Phase II | 2018 | $995.2K |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2017 | $225K |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2015 | $392.4K |
Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.
Frequently asked questions
- What does Scene do?
- Scene provides digital medication adherence programs combining video check-ins and human engagement by nurses and pharmacists to improve patient adherence and health outcomes across health systems and care organizations. The company evolved from emocha, a Johns Hopkins-originated technology that has expanded globally to address medication nonadherence in infectious disease treatment and other conditions.
- Who founded Scene?
- Scene was founded by Sebastian Seiguer, Morad Elmi, Sebastian Seiguer, JD, MBA, Morad E..
- Who are Scene's investors?
- Scene's investors include Gaingels, Kapor Capital, TCP Venture Capital, ABS Capital Partners, Bold Capital Partners, Greycroft, PTX Capital, super{set}.
- Where is Scene headquartered?
- Scene is headquartered in Baltimore, US.